&nbsp;

CancerScreeningToolkitLungScreening-FR.pdf

New

Jun 2025

Ressources sur le dépistage du cancer destinées aux Premières Nations, aux Inuits, aux Métis et aux Autochtones en milieu urbain

Drug

iBRUtinib

Other Name(s): Imbruvica®

Quick Link(s): Drug Monograph, Patient Info Sheet

Updated

Jun 2025

Regimen

IBRU

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

Exceptional Access Program

iBRUtinib - For relapsed and refractory Mantle Cell Lymphoma, according to clinical criteria

Drugs Used:

iBRUtinib

Quick Link(s):

Regimen Monograph

Updated

Jun 2025

Regimen

IBRU

Cancer Type:

Hematologic,

Leukemia - Chronic Lymphocytic (CLL)

Intent: Palliative

Funding:

Exceptional Access Program

iBRUtinib - For patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), according to specific criteria.

Drugs Used:

iBRUtinib

Quick Link(s):

Regimen Monograph

Updated

Jun 2025

Regimen

IBRU

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

Exceptional Access Program

iBRUtinib - For the treatment of patients with relapsed or refractory Waldenstrӧm Macroglobulinemia, as monotherapy, based on criteria

Drugs Used:

iBRUtinib

Quick Link(s):

Regimen Monograph

Updated

Jun 2025

Regimen

IBRU

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's High Grade

Intent: Palliative

Drugs Used:

iBRUtinib (Unfunded)

Quick Link(s):

Regimen Monograph

Updated

Jun 2025

Guidelines and Advice

Bone Health and Bone-Targeted Therapies for Prostate Cancer

Status: In-Review
ID: 3-14
Version: 2

Sep 2016

Document

CervicalCancerPreventionScreeningPathwayMap.pdf

New

Jun 2025

Document

CervicalCancerDiagnosisPathwayMap.pdf

New

Jun 2025

Document